ALHC241115C15000
- 0.25
- -0.05-16.67%
Alignment Healthcare Newsroom
TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $13
Piper Sandler Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $14
Alignment Healthcare Analyst Ratings
A Quick Look at Today's Ratings for Alignment Healthcare(ALHC.US), With a Forecast Between $8 to $14
Alignment Healthcare Is Maintained at Neutral by UBS
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $12
Barclays Maintains Alignment Healthcare(ALHC.US) With Sell Rating, Raises Target Price to $8
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $14
William Blair Initiates Alignment Healthcare(ALHC.US) With Buy Rating
Alignment Healthcare Analyst Ratings
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $14
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $14
Buy Rating Affirmed for Alignment Healthcare on Strong Growth and Operational Efficiency Prospects Into 2025
Alignment Healthcare Analyst Ratings
TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $10
Piper Sandler Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $10
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Alignment Healthcare (ALHC) and Akoya Biosciences (AKYA)
Alignment Healthcare Analyst Ratings
Barclays Maintains Underweight on Alignment Healthcare, Raises Price Target to $7
TD Cowen Initiates Alignment Healthcare(ALHC.US) With Buy Rating, Announces Target Price $10